Related Experiment Videos

Takayasu arteritis in children

Safia Al Abrawi1, Marine Fouillet-Desjonqueres, Louis David

  • 1Département de pédiatrie, Hôpital Edouard-Herriot and Université Claude-Bernard Lyon1, Lyon, France. r.cimaz@meyer.it.

Insights

Takayasu arteritis (TA), a large vessel vasculitis, can affect children, presenting with hypertension and ischemic pain. Early diagnosis and treatment with immunosuppressants and antihypertensives are crucial for managing this rare pediatric condition.

Area of Science:

  • Pediatric Rheumatology
  • Vascular Inflammation
  • Autoimmune Diseases

Background:

  • Takayasu arteritis (TA) is a rare large vessel vasculitis predominantly affecting young women.
  • While typically diagnosed in the second and third decades of life, TA can manifest in childhood, even in patients as young as 24 months.
  • Understanding pediatric TA is critical due to its potential for severe vascular complications.

Purpose of the Study:

  • To describe four pediatric cases of Takayasu arteritis.
  • To summarize key findings from published studies on childhood TA.
  • To highlight clinical presentation, diagnostic features, and treatment outcomes in pediatric TA.

Main Methods:

  • Retrospective case series of four children diagnosed with TA.
  • Review of relevant published literature on pediatric Takayasu arteritis.
  • Analysis of clinical data including age, ethnicity, symptoms, imaging, inflammatory markers, and treatment responses.

Main Results:

  • The mean age of presentation in the four cases was 11 years (range 8-15).
  • Common presentations included arterial hypertension and systemic symptoms, with ischemic pain in limbs, chest, and abdomen.
  • Angiography revealed frequent involvement of the left subclavian and common carotid arteries; two patients had renal artery stenosis.
  • One patient had an associated Wiskott-Aldrich syndrome, an immune deficiency.

Conclusions:

  • Takayasu arteritis in children presents with diverse symptoms, often including hypertension and ischemic manifestations.
  • Prompt diagnosis supported by imaging and inflammatory markers is essential for effective management.
  • Treatment involves immunosuppressants and antihypertensives, with potential need for surgery, and long-term monitoring is required.

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Pericarditis I: Introduction01:22

Pericarditis I: Introduction

Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Aneurysm I: Introduction01:30

Aneurysm I: Introduction

An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...